Frontiers in Neurology | Multiple Sclerosis and Neuroimmunology

Original Research

Published on 17 Nov 2022

Ovarian resection in anti-N-methyl-D-aspartate receptor encephalitis: A comparison of surgical approaches

in Multiple Sclerosis and Neuroimmunology

Yajur Iyengar
Julien Hébert
Seth A. Climans
Alexandra Muccilli
Sydney Lee
Abhilasha P. Boruah
Kiran T. Thakur
Jonathon Solnik
Richard A. Wennberg
Gregory S. Day

Frontiers in Neurology

doi 10.3389/fneur.2022.1043785

2,276 views
2 citations

Original Research

Published on 15 Nov 2022

Elevated plasma D-dimer levels in patients with anti-N-methyl-D-aspartate receptor encephalitis

in Multiple Sclerosis and Neuroimmunology

Yingzhe Shao
Juan Du
Yajun Song
Yanfei Li
Lijun Jing
Zhe Gong
Ranran Duan
Yaobing Yao
Yanjie Jia
Shujie Jiao

Frontiers in Neurology

doi 10.3389/fneur.2022.1022785

1,945 views
2 citations

Original Research

Published on 14 Nov 2022

Rebaseline no evidence of disease activity (NEDA-3) as a predictor of long-term disease course in a Norwegian multiple sclerosis population

in Multiple Sclerosis and Neuroimmunology

Cecilia Smith Simonsen
Heidi Øyen Flemmen
Line Broch
Kamilla Brekke
Cathrine Brunborg
Pål Berg-Hansen
Elisabeth Gulowsen Celius

Frontiers in Neurology

doi 10.3389/fneur.2022.1034056

4,415 views
6 citations

Review

Published on 10 Nov 2022

The role of type I IFN in autoimmune and autoinflammatory diseases with CNS involvement

in Multiple Sclerosis and Neuroimmunology

Sylvia Raftopoulou
Anna Rapti
Dimitris Karathanasis
Maria Eleftheria Evangelopoulos
Clio P. Mavragani

Frontiers in Neurology

doi 10.3389/fneur.2022.1026449

6,014 views
13 citations

Brief Research Report

Published on 10 Nov 2022

Longitudinal SARS-CoV-2 humoral response in MS patients with and without SARS-CoV-2 infection prior to vaccination

in Multiple Sclerosis and Neuroimmunology

Koos P. J. van Dam
Laura Hogenboom
Eileen W. Stalman
Laura Y. L. Kummer
Maurice Steenhuis
Jim B. D. Keijser
Anja ten Brinke
S. Marieke van Ham
Taco W. Kuijpers
Theo Rispens

Frontiers in Neurology

doi 10.3389/fneur.2022.1032830

1,520 views
5 citations

Original Research

Published on 09 Nov 2022

Fertility preferences and unmet need for family planning in women with multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Lorena López-Reyes
Claudia Guío-Sánchez
Catalina González-Uribe
Simón Cárdenas-Robledo

Frontiers in Neurology

doi 10.3389/fneur.2022.1035596

2,902 views
5 citations

Review

Published on 07 Nov 2022

Myelitis features and outcomes in CNS demyelinating disorders: Comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD

in Multiple Sclerosis and Neuroimmunology

Giulia Fadda
Eoin P. Flanagan
Laura Cacciaguerra
Jiraporn Jitprapaikulsan
Paolo Solla
Pietro Zara
Elia Sechi

Frontiers in Neurology

doi 10.3389/fneur.2022.1011579

16,729 views
41 citations

Systematic Review

Published on 03 Nov 2022

Seizure outcome-related factors in autoimmune encephalitis: A systematic review and meta-analysis

in Multiple Sclerosis and Neuroimmunology

Peijuan Luo
Rui Zhong
Qingling Chen
Weihong Lin

Frontiers in Neurology

doi 10.3389/fneur.2022.991043

2,574 views
2 citations

Original Research

Published on 03 Nov 2022

Sex and age differences in the Multiple Sclerosis prodrome

in Multiple Sclerosis and Neuroimmunology

Fardowsa L. A. Yusuf
José M. A. Wijnands
Mohammad Ehsanul Karim
Elaine Kingwell
Feng Zhu
Charity Evans
John D. Fisk
Yinshan Zhao
Ruth Ann Marrie
Helen Tremlett

Frontiers in Neurology

doi 10.3389/fneur.2022.1017492

3,820 views
10 citations

Case Report

Published on 02 Nov 2022

Role of responsive neurostimulation and immunotherapy in refractory epilepsy due to autoimmune encephalitis: A case report

in Multiple Sclerosis and Neuroimmunology

Stephanie H. Chen
Pamela K. O'Dea
Bahareh Sianati
David R. Benavides

Frontiers in Neurology

doi 10.3389/fneur.2022.1028290

2,512 views
2 citations

Original Research

Published on 31 Oct 2022

Persistent “MRI-negative” lupus myelitis-disease presentation, immunological profile and outcome

in Multiple Sclerosis and Neuroimmunology

Shambaditya Das
Biman Kanti Ray
Arka Prava Chakraborty
Abhirup Banerjee
Alak Pandit
Gautam Das
Souvik Dubey

Frontiers in Neurology

doi 10.3389/fneur.2022.968322

4,159 views
5 citations

Study Protocol

Published on 28 Oct 2022

Effect of transcutaneous posterior tibial nerve stimulation and repetitive transcranial magnetic stimulation on neurogenic overactive bladder symptoms in female patients with multiple sclerosis: The study protocol of a randomized controlled study

in Multiple Sclerosis and Neuroimmunology

Pinar Atak Çakir
Fatma Mutluay
Lütfü Hanoğlu
Vahit Güzelburç

Frontiers in Neurology

doi 10.3389/fneur.2022.1011502

3,560 views
7 citations

Original Research

Published on 28 Oct 2022

Oligoclonal M bands and cervical spinal cord lesions predict early secondary progressive multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Carmen Alcalá Vicente
Laura Lacruz
Francisco Gascón
Sara Carratalà
Carlos Quintanilla-Bordás
Maria T. Sanz
María Carcelén-Gadea
Javier Mallada
Joan Carreres
Laura Gabaldón Torres

Frontiers in Neurology

doi 10.3389/fneur.2022.991596

2,619 views
2 citations

Case Report

Published on 26 Oct 2022

Anti-glycine receptor antibody-positive progressive encephalomyelitis with rigidity and myoclonus initially presenting with one-sided stiff face: A case report

in Multiple Sclerosis and Neuroimmunology

Ken-Ichi Irie
Takahisa Tateishi
Taiga Moritaka
Naonori Sakurada
Shinsuke Kikuchi
Takayuki Taniwaki

Frontiers in Neurology

doi 10.3389/fneur.2022.1021437

3,863 views
3 citations

Mini Review

Published on 20 Oct 2022

Meningo-cortical manifestations of myelin oligodendrocyte glycoprotein antibody-associated disease: Review of a novel clinico-radiographic spectrum

in Multiple Sclerosis and Neuroimmunology

Adrian Budhram
Ario Mirian
Manas Sharma

Frontiers in Neurology

doi 10.3389/fneur.2022.1044642

7,958 views
17 citations

Mini Review

Published on 20 Oct 2022

Societal economic burden of multiple sclerosis and cost-effectiveness of disease-modifying therapies

in Multiple Sclerosis and Neuroimmunology

Steven Simoens

Frontiers in Neurology

doi 10.3389/fneur.2022.1015256

5,786 views
13 citations